Related Experiment Video
Updated: Dec 22, 2025

08:30
Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures
Published on: January 19, 2019
9.6K
Charge-Shifting Polycations Based on N,N-(dimethylamino)ethyl Acrylate for Improving Cytocompatibility During DNA
Samantha Ros1, Jessica S Freitag2, David M Smith2
1Department of Chemistry and Chemical Biology, McMaster University, Hamilton, Ontario L8S 4L8, Canada.
ACS Omega
|May 5, 2020
Summary
New synthetic polycations, called PAD copolymers, show promise for DNA delivery. These charge-shifting polymers reduce toxicity while maintaining high cell uptake efficiency, offering a safer alternative to viral vectors.
Area of Science:
- Polymer Chemistry
- Biomaterials Science
- Gene Delivery
Background:
- Synthetic polycations are cost-effective, stable alternatives to viral vectors for DNA delivery.
- Developing non-viral vectors with improved safety and efficacy is crucial for gene therapy.
Purpose of the Study:
- To synthesize and evaluate charge-shifting polycations (PAD copolymers) for in vitro DNA delivery.
- To assess the cytotoxicity and cell uptake efficiency of PAD copolymers compared to existing non-viral vectors.
Main Methods:
- RAFT polymerization was used to synthesize PAD copolymers with controlled molecular weights.
- Hydrolysis studies determined the charge-shifting rates of the polycations.
- In vitro studies evaluated cell viability and DNA polyplex uptake in HeLa cells.
Main Results:
- PAD copolymers exhibited tunable charge-shifting hydrolysis, forming polyampholytes.
- PAD copolymers showed comparable or higher cell viability than non-charge-shifting polycations and PEI.
- Cell uptake efficiency of PAD/DNA polyplexes exceeded that of PEI polyplexes.
Conclusions:
- PAD copolymers, particularly PAD80, demonstrate suitable charge-shifting hydrolysis for DNA delivery.
- Reduced cytotoxicity and high uptake efficiency make PAD copolymers a promising non-viral gene delivery system.
- The resulting polyampholytes may enhance long-term cytocompatibility.

